Use access key #2 to skip to page content.

portefeuille (99.50)

fund trades

Recs

9

December 11, 2010 – Comments (132)

I will post the trades I make and some performance statistics. I will add a list showing all trades or some "background information" related to the trades occasionally.

What this "fund" is about is described here.

rel. change of fund (March 8, 2010 - December 10, 2010): 41.83%.

trades in spreadsheet (until December 10, 2010).

132 Comments – Post Your Own

#1) On December 11, 2010 at 7:10 PM, portefeuille (99.50) wrote:

fund trading volume (March 8, 2010 - December 10, 2010): around $57.8 million.

Report this comment
#2) On December 11, 2010 at 7:39 PM, SultanOfSwing (97.82) wrote:

porte,

This is quite impressive.  Are there any short sales here or are they all longs?  I'm guessing by reading your Apr 8, "Fund Strategy" blog, that you make over 99% long trades.  I did a search for "buy to cover" and only got one hit.  Am I correct?

Thanks for the info.  It's a good study.

Report this comment
#3) On December 11, 2010 at 11:58 PM, portefeuille (99.50) wrote:

#2 Yes, the "fund" almost exclusively has long positions. Currently the only short position are -1400 VMW shares which should be viewed as part of an arbitrage position. A part of the 23300 EMC shares are the other part of that arbitrage position. The fund currently has a few S&P 500 index put options.

Report this comment
#4) On December 12, 2010 at 12:01 AM, portefeuille (99.50) wrote:

The fund currently has a few S&P 500 index put options.

The fund currently has a few put options on the SPY ETF. It also has a few put options on the IWM ETF.

Report this comment
#5) On December 12, 2010 at 1:17 AM, portefeuille (99.50) wrote:

the largest positions (number of shares, ticker, name, current value, current share price, break-even).

92350, ALNY, Alnylam Pharmaceuticals, 874554.50 USD, 9.47 USD, 10.58 USD.
8100, IBB, iShares Nasdaq Biotechnology Index Fund, 736857.00 USD, 90.97 USD, 89.15 USD.
32900, ATPG, ATP Oil & Gas, 520149.00 USD, 15.81 USD, 11.25 USD.
23300, EMC, 22.25 USD, 16.72 USD, 518425.00 USD.
40200, EXAS, Exact Sciences, 229542.00 USD, 5.71 USD, 5.68 USD.
14110, MNTA, Momenta Pharmaceuticals, 207417.00 USD, 14.70 USD, 15.66 USD,
191100, ANDS, Anadys Pharmaceuticals, 194922.00 USD, 1.02 USD, 1.16 USD,
4450, FXI, iShares FTSE/Xinhua China 25 Index Fund, 193263.50 USD, 43.43 USD, 43.67 USD.
3270, QQQQ, Powershares QQQ (NASDAQ 100 index fund), 178198.65 USD, 54.495 USD, 53.27 USD.

Report this comment
#6) On December 12, 2010 at 1:27 AM, portefeuille (99.50) wrote:

trades in spreadsheet (until December 10, 2010).

trades in spreadsheet (until December 10, 2010).

Report this comment
#7) On December 12, 2010 at 1:32 AM, portefeuille (99.50) wrote:

23300, EMC, 22.25 USD, 16.72 USD, 518425.00 USD.

23300, EMC, 518425.00 USD, 22.25 USD, 16.72 USD.

 

okay, now everything should be alright ...

Report this comment
#8) On December 12, 2010 at 2:27 AM, portefeuille (99.50) wrote:

the largest positions.



enlarge




enlarge

 



enlarge




enlarge

 



enlarge




enlarge

 



enlarge




enlarge

 



enlarge




enlarge

 



enlarge




enlarge

 



enlarge




enlarge

 



enlarge




enlarge

 



enlarge




enlarge

Report this comment
#9) On December 12, 2010 at 12:45 PM, rexlove (99.43) wrote:

I hope you're right about ALNY. I put some real money down on this one. I always like a couple of speculative picks in my portfolio. Hope this one pans out. 

Report this comment
#10) On December 12, 2010 at 3:57 PM, rofgile (99.31) wrote:

Do you really believe in RNA-interference in humans as a treatment?

How do you get the siRNA to the human cells, and keep delivering this effectively, and why wouldn't similar issues as what happened with gene-therapy in the 1990's be with RNAi?

---

I'm a bit biased, as I think RNAi is.. mm.. semi-BS for a treatment.

I looked at the releases from ALNY about their "1st in RNAi drug trials".  They showed in stage 2 that it was safe.  But, they didn't show almost any real information if it worked.  For all we know, maybe they gave a totally ineffectual drug that didn't reach cells or do much for effects, but wasn't toxic.

---

 Why are you so confident in ALNY, porte?

 -Rof 

Report this comment
#11) On December 12, 2010 at 4:45 PM, Momentum21 (93.61) wrote:

While the mechanism is called RNAi, the therapeutic agents are the so-called short interfering RNAs (siRNA) that consist of ~21 nucleotides of double-stranded RNA. Dr. MacLachlan said that nanoparticles coated with lipids encasing the payload siRNA represent an emerging new approach for delivery. “In the early days, researchers were using naked siRNA or chemically modified versions. Although initially there were some good in vivo results, further studies were less encouraging. We found, however, specially coated nanoparticles can potentiate delivery by 1,000-fold.”

From here 

The cash position of ALNY helps their ability to play on in this long battle. Obviously most are down on the potential because it has been hyped for so many years. Orelli and zzlangerhans have some pretty good stuff posted here as well...but Porte got me interested when I saw his enthusiasm for it. : )

The Roche decision seemed to be more about general cost gutting then giving up on RNAi...

Under $10 is pretty compelling when considering the potential upside and cash position "protecting" the downside.  

Report this comment
#12) On December 12, 2010 at 5:07 PM, rofgile (99.31) wrote:

Ok.. so you have "nanoparticles coated with lipids", sounds fancy right?  All those are are little oil bubbles holding in your rna.

And there is research interest in that, fine.

---

Where I am doubtful is that the rnai will really reach every cell that it needs to for X disease treatment.  Further, supposing that you do reach the cells, and the rna gets into the cells, and silences the gene.  Fantastic - bravo.

But, what about the side effects such as cancer, which I could potentially see happening when you begin flipping genes on/off? The gene therapy era died abruptly when it was realized that when you give a working copy of a gene by viral delivery without bad things also happening sometimes (other genes getting knocked out, regulators screwed up.. etc).  Why couldn't similar problems happen in humans with rnaI?

My last note is that rnaI cannot be delivered through a pill.  It'll require direct injections into the blood, organs affected by disease.  (Because stomach acids would easily kill lipid nanoparticles and rna).  So, you've got a not quite convenient treatment with high cost.

 -Rof 

Report this comment
#13) On December 12, 2010 at 5:19 PM, rofgile (99.31) wrote:

Too make an analogy - 

 rnaI disease treatments to current drug treatments is similar to:

 novel algae oil compared to conventional oil 

---

 In theory it works and could be a neat product.  In small lab experiments you can get some results.  Its exciting and investors can buy into it.  But - how do you feel about the algae oil companies?  Would you put money in them?

 -Rof 

Report this comment
#14) On December 12, 2010 at 7:30 PM, portefeuille (99.50) wrote:

Why are you so confident in ALNY, porte?

It is just part of an "RNAi basket" I have in the "fund" and in my portfolio (see this post). And of those stocks it is currently my favourite one. My knowledge in the field is rather limited, so it would be pretty useless to post any details on ALNY or the other "RNAi stocks" ...

Report this comment
#15) On December 12, 2010 at 7:45 PM, portefeuille (99.50) wrote:

#15 I do by the way usually like a certain stock for the obvious reasons. I just read a few things and then try to evaluate "the whole thing". And quite a few times the "buys" and "sells" are to some extent "event driven" (also usually the "obvious" events that can be found via yahoo finance in a few seconds. And I almost never look at stuff like the "details of the balance sheet", "insider trading", "dividend yield", "cash flow" and similar stuff. Not only am I not an expert in the related fields, they are not even fun to look at, in contrast to the "scientific aspects" of some biotech stocks for example.

I also spend far too little time on the scientific aspects, so it probably best to ignore everthing I post that appears somewhat "original". Well, I usually just post links, so there is little danger of encountering "original content". Just be careful when you do, hehe ...

Report this comment
#16) On December 12, 2010 at 8:09 PM, portefeuille (99.50) wrote:

seconds.

seconds).

so it

so it is

Report this comment
#17) On December 12, 2010 at 8:46 PM, portefeuille (99.50) wrote:

something for those equally bored by "balance sheets" ...

The promise of ion beam cancer therapy

 

(that "topic" was already mentioned in comment #5 here. by me.)

Report this comment
#18) On December 12, 2010 at 9:00 PM, portefeuille (99.50) wrote:

(from here)

 

Report this comment
#19) On December 12, 2010 at 9:16 PM, portefeuille (99.50) wrote:

sell 6000 MIPI, limit 0.20 USD.

Report this comment
#20) On December 12, 2010 at 9:40 PM, portefeuille (99.50) wrote:

sell 50 VNM, limit 30.20 USD,
sell 2600 VOF:LN, limit 1.97 USD.

Report this comment
#21) On December 12, 2010 at 11:08 PM, Momentum21 (93.61) wrote:

rofgile (< 20) - the bottom line is that I am trying to make an educated gamble on "successes" before the ultimate failure that you see playing out (if we both assume that this failure outcome is more "probable"). Like all seemingly no-brainer shorts the road is long and winding.

Your analogy is worth considering. And I would not invest in biofuels at the moment since I think we have a long list of sources that might be subsidized in front of this one...I just don't like it personally. Although you did get me looking at a few charts that require some investigation! 

RNAi as a treatment for HIV and/or Cancer presents more keen interest for me. Even a trivial "breakthrough" in the delivery piece could be exciting short-term...it is doubtful that I will be a holder my full position when a successful endgame is potentially reached down the road/ "the cure".

Ultimately we can both be right and prosper (although I do realize you weren't asking me the question initially.)  : )

Report this comment
#22) On December 13, 2010 at 6:17 AM, portefeuille (99.50) wrote:

sell 2600 VOF:LN, limit 1.97 USD.

change that to

sell 2000 VOF:LN, limit 1.90 USD.

Report this comment
#23) On December 13, 2010 at 6:22 AM, portefeuille (99.50) wrote:

rel. change of fund (March 8, 2010 - December 13, 2010): 42.1%.

Report this comment
#24) On December 13, 2010 at 8:00 AM, portefeuille (99.50) wrote:

sold 2000 VOF:LN 1.91 USD.

Report this comment
#25) On December 13, 2010 at 9:35 AM, portefeuille (99.50) wrote:

sell 1500 ALNY, limit 9.68 USD.

Report this comment
#26) On December 13, 2010 at 9:40 AM, portefeuille (99.50) wrote:

sold 6000 MIPI 0.255 USD.

Report this comment
#27) On December 13, 2010 at 9:43 AM, portefeuille (99.50) wrote:

sell 2300 EMC, limit 22.47 USD.

Report this comment
#28) On December 13, 2010 at 9:43 AM, portefeuille (99.50) wrote:

sold 2300 EMC 22.49 USD.

Report this comment
#29) On December 13, 2010 at 10:05 AM, portefeuille (99.50) wrote:

Report this comment
#30) On December 13, 2010 at 10:08 AM, portefeuille (99.50) wrote:

Report this comment
#31) On December 13, 2010 at 10:10 AM, portefeuille (99.50) wrote:

Report this comment
#32) On December 13, 2010 at 10:11 AM, portefeuille (99.50) wrote:

Report this comment
#33) On December 13, 2010 at 10:19 AM, portefeuille (99.50) wrote:

Report this comment
#34) On December 13, 2010 at 10:49 AM, portefeuille (99.50) wrote:

buy 800 CYTK, limit 2.36 USD.

Report this comment
#35) On December 13, 2010 at 10:51 AM, portefeuille (99.50) wrote:

bought 800 CYTK 2.35 USD.

sell 85 AIXG, limit 37.65 USD.

Report this comment
#36) On December 13, 2010 at 10:56 AM, portefeuille (99.50) wrote:

sold 85 AIXG 37.75 USD.

sell 90 JDSU, limit 14.25 USD.

Report this comment
#37) On December 13, 2010 at 10:58 AM, portefeuille (99.50) wrote:

sold 90 JDSU 14.30 USD.

Report this comment
#38) On December 13, 2010 at 12:13 PM, portefeuille (99.50) wrote:

sell 2400 OPTR, limit 10.66 USD.

Report this comment
#39) On December 13, 2010 at 12:22 PM, portefeuille (99.50) wrote:

sold 2400 OPTR 10.74 USD.

Report this comment
#40) On December 13, 2010 at 6:16 PM, portefeuille (99.50) wrote:

Goldman Sachs Resumes EMC (EMC) at Buy, Sees 22% Upside

Goldman Sachs Resumes NetApp (NTAP) at Neutral

UPDATE - Barclays Upgrades NetApp (NTAP) to Overweight; Can't Ignore Momentum in the Cloud, Even Up Here

Report this comment
#41) On December 13, 2010 at 6:48 PM, portefeuille (99.50) wrote:

sold 50 VNM 30.20 USD.

Report this comment
#42) On December 13, 2010 at 7:27 PM, portefeuille (99.50) wrote:

----------------

Is anyone left after data-storage buyout wave?

...

Big tech companies are specifically reacting to the rise of cloud computing, in which businesses tap computing power in a network instead of in-house data centers, a trend which has underscored the importance of data storage and management technologies.

As a result, there’s been much speculation that tech giants could go after even big data-storage players such as by EMC and NetApp Inc /quotes/comstock/15*!ntap/quotes/nls/ntap (NTAP 55.89, +0.31, +0.56%)  .

“Within hardware, we believe networked storage assets represent the most attractive potential candidates, EMC and NetApp included, while most other hardware companies fit into the potential acquirer category,” Goldman Sachs Bill Shope said in a note Monday.

“We believe Dell, in particular, will need to acquire a significant amount of enterprise technology if it is going to successfully transition from a PC-centric company to an enterprise solutions leader,” he added.

Analyst Paul Mansky of Canaccord Genuity said he didn’t see a merger deal involving big public companies such as EMC or NetApp as likely.

But he noted in an e-mail that a “a tax holiday on international cash repatriation” could serve “as a potential catalyst to get the large tech companies more interested in a ‘mega deal’.”

NetApp in particularly has been the subject of much M&A speculation. Barclays Capital analyst Ben Reitzes on Monday upgraded the stock to overweight from equal weight saying in a note, “We believe NetApp is a long-term winner due to virtualization and cloud computing.”

Reitzes also argued, “We find it hard to ignore the consolidation argument for NetApp given its growth prospects and the ability for a larger acquirer to cut significant operating expenses.”

----------------

Report this comment
#43) On December 13, 2010 at 7:31 PM, portefeuille (99.50) wrote:

Dell-EMC Relationship “On The Rocks” After Storage Acquisition

Report this comment
#44) On December 14, 2010 at 1:09 AM, portefeuille (99.50) wrote:

http://www.fullermoney.com/content/2010-12-10/HSBCVietnamInsightsNov10.pdf

http://quicktake.morningstar.com/etfnet/Holdings.aspx?Country=&Symbol=VNM

also see this post.

 

currently 50 VNM and 4000 VOF:LN "shares" in the fund.

Report this comment
#45) On December 14, 2010 at 1:18 AM, portefeuille (99.50) wrote:

#46



enlarge

(from here)

Report this comment
#46) On December 14, 2010 at 5:30 AM, portefeuille (99.50) wrote:

buy 160000 DSCO, limit 0.19 USD in extended or regular trading.

Report this comment
#47) On December 14, 2010 at 11:35 AM, portefeuille (99.50) wrote:

Cypress Board Rejects Ramius' $6.00 All-Cash Offer

 

currently 280 CYPB shares in the fund with break-even of around -3.50 USD.

Report this comment
#48) On December 14, 2010 at 11:38 AM, portefeuille (99.50) wrote:

sold 550 CYPB 5.39 USD (see comments #77,78 here).

Report this comment
#49) On December 14, 2010 at 11:42 AM, portefeuille (99.50) wrote:

bought 160000 DSCO 0.177 USD.

Report this comment
#50) On December 14, 2010 at 12:32 PM, portefeuille (99.50) wrote:

Veeco, Aixtron Downgrades Stall LED Stocks

 

currently 1485 AIXG shares in the fund with break-even of around 43.07 USD,
currently 765 VECO shares in the fund with break-even of around 13.28 USD.

Report this comment
#51) On December 14, 2010 at 12:34 PM, portefeuille (99.50) wrote:

sold 1500 ALNY 9.68 USD.

Report this comment
#52) On December 14, 2010 at 12:48 PM, portefeuille (99.50) wrote:

sell 70 GXDX, limit 21 USD.

Report this comment
#53) On December 14, 2010 at 12:49 PM, portefeuille (99.50) wrote:

sold 70 GXDX 21 USD.

Report this comment
#54) On December 14, 2010 at 1:17 PM, portefeuille (99.50) wrote:

sell 750 MNKD, limit 8.33 USD.

Report this comment
#55) On December 14, 2010 at 1:19 PM, portefeuille (99.50) wrote:

sold 750 MNKD 8.34 USD.

currently 450 MNKD shares in the fund with break-even of around 20.23 USD.

Report this comment
#56) On December 14, 2010 at 3:36 PM, portefeuille (99.50) wrote:

buy 170 VECO, limit 41.90 USD.

Report this comment
#57) On December 14, 2010 at 3:36 PM, portefeuille (99.50) wrote:

bought 170 VECO 41.75 USD.

Report this comment
#58) On December 14, 2010 at 3:54 PM, portefeuille (99.50) wrote:

#44,45

DB X-TRACKERS FTSE VIETNAM INDEX ETF

factsheet (pdf)

DB X-TRACKERS FTSE VIETNAM INDEX ETF in Xetra trading.



enlarge

 



enlarge

Report this comment
#59) On December 15, 2010 at 5:38 AM, portefeuille (99.50) wrote:

Sweden Raises Rate to 1.25%, Repeats Tightening Plans

Report this comment
#60) On December 15, 2010 at 8:33 AM, portefeuille (99.50) wrote:

sell 900 ARIA, limit 4.38 USD.

currently 5000 ARIA shares in the fund with break-even of around 1.34 USD.

Report this comment
#61) On December 15, 2010 at 8:42 AM, portefeuille6 (99.68) wrote:

buy 3700 ROSG, limit 1.15 USD.

currently 1600 ROSG shares in the fund with break-even of around 0.62 USD.

Report this comment
#62) On December 15, 2010 at 9:21 AM, portefeuille (99.50) wrote:

sell 280 CYPB, limit 6.45 USD in extended or regular trading.

 

Cypress Bioscience Agrees To Be Acquired by Ramius LLC and Royalty Pharma for $6.50 Per Share in Cash

Report this comment
#63) On December 15, 2010 at 9:22 AM, portefeuille (99.50) wrote:

sold 280 CYPB 6.46 USD.

Report this comment
#64) On December 15, 2010 at 9:31 AM, portefeuille (99.50) wrote:




enlarge

 



enlarge

Report this comment
#65) On December 15, 2010 at 9:33 AM, portefeuille (99.50) wrote:

#64 The June 21 trade was "bottom picking", hehe ...

Report this comment
#66) On December 15, 2010 at 9:34 AM, portefeuille (99.50) wrote:

#65 ... a few days too early, obviously ...

Report this comment
#67) On December 15, 2010 at 9:36 AM, portefeuille (99.50) wrote:

buy 700 INHX, limit 2.14 USD.

Report this comment
#68) On December 15, 2010 at 9:45 AM, portefeuille (99.50) wrote:

sold 900 ARIA 4.49 USD,
bought 700 INHX 2.13 USD.

 

sell 3000 ALNY, limit 9.77 USD.

Report this comment
#69) On December 15, 2010 at 9:48 AM, portefeuille (99.50) wrote:

sold 3000 ALNY 9.78 USD.

Report this comment
#70) On December 15, 2010 at 9:53 AM, portefeuille (99.50) wrote:

sell 40000 DSCO 0.192 USD.

Report this comment
#71) On December 15, 2010 at 9:56 AM, portefeuille (99.50) wrote:

sell 200 MNKD, limit 8.92 USD.

Report this comment
#72) On December 15, 2010 at 10:05 AM, portefeuille (99.50) wrote:

sold 200 MNKD 8.94 USD.

 

buy 900 PAH3:GY, limit 60.25 EUR.

cancel that order.

Report this comment
#73) On December 15, 2010 at 10:23 AM, portefeuille2 (99.51) wrote:

buy 800 EWD, limit 30.62 USD.

 

http://quicktake.morningstar.com/etfnet/Holdings.aspx?Country=&Symbol=EWD

Report this comment
#74) On December 15, 2010 at 10:24 AM, portefeuille2 (99.51) wrote:

bought 800 EWD 30.565 USD.

Report this comment
#75) On December 15, 2010 at 10:27 AM, portefeuille2 (99.51) wrote:

sell 1400 EXEL, limit 7.40 USD.

Report this comment
#76) On December 15, 2010 at 10:31 AM, portefeuille2 (99.51) wrote:

sold 1400 EXEL 7.47 USD.

currently 6250 EXEL shares in the fund with break-even of around -9.1285 USD (yeay!).

Report this comment
#77) On December 15, 2010 at 10:42 AM, portefeuille (99.50) wrote:

sold 40000 DSCO 0.192 USD.

Report this comment
#78) On December 15, 2010 at 10:51 AM, Momentum21 (93.61) wrote:

Looks like I missed out on the meat of the EXEL move...congrats. I sold at $4.58... : )

Perhaps DiSCO will help make up for that...and I really like Sweden from what I have been reading as well.  

Report this comment
#79) On December 15, 2010 at 11:27 AM, portefeuille (99.50) wrote:

sell 70 FNSR, limit 26.60 USD.

Report this comment
#80) On December 15, 2010 at 11:31 AM, portefeuille (99.50) wrote:

sold 70 FNSR 26.63 USD.

currently 110 FNSR shares in the fund with break-even of around 1.33 USD.

Report this comment
#81) On December 15, 2010 at 11:41 AM, portefeuille9 (95.13) wrote:

sell 220 VPHM, limit 17.50 USD.

Report this comment
#82) On December 15, 2010 at 11:44 AM, portefeuille9 (95.13) wrote:

sold 220 VPHM 17.59 USD.

currently 210 VPHM shares in the fund with break-even of around 2.68 USD.

Report this comment
#83) On December 15, 2010 at 12:01 PM, portefeuille (99.50) wrote:

VMWare: Microsoft, Oracle trailing us

 

currently -1400 VMW shares in the fund with break-even of around 132.13 USD.
currently 21000 EMC shares in the fund with break-even of around 16.08 USD.

Report this comment
#84) On December 15, 2010 at 12:11 PM, portefeuille (99.50) wrote:

#83 It is VMware by the way, not VMWare ...

 

Virtual machines, real money

Report this comment
#85) On December 15, 2010 at 12:42 PM, portefeuille (99.50) wrote:

buy to cover 400 VMW, limit 86.20 USD.

Report this comment
#86) On December 15, 2010 at 12:43 PM, portefeuille (99.50) wrote:

bought to cover 400 VMW 86.02 USD.

Report this comment
#87) On December 15, 2010 at 12:51 PM, portefeuille (99.50) wrote:

The EMC/VMW position is currently "in the green" by around (21000 * (22.63 - 16.08) + 1000 * (150.57 - 85.48)) USD = 202640 USD.

Report this comment
#88) On December 15, 2010 at 12:57 PM, portefeuille (99.50) wrote:

#87 If you find that expression "asymmetric", you might prefer this version.

(21000 * (22.63 - 16.08) + (-1000) * (85.48 - 150.57)) USD = 202640 USD.

Report this comment
#89) On December 15, 2010 at 12:58 PM, portefeuille (99.50) wrote:

buy to cover 300 VMW, limit 86 USD.

Report this comment
#90) On December 15, 2010 at 12:59 PM, portefeuille (99.50) wrote:

bought to cover 300 VMW 84.95 USD.

Report this comment
#91) On December 15, 2010 at 3:05 PM, portefeuille (99.50) wrote:

buy 160 MNKD, limit 8 USD.

Report this comment
#92) On December 15, 2010 at 3:06 PM, portefeuille (99.50) wrote:

bought 160 MNKD 7.68 USD.

Report this comment
#93) On December 16, 2010 at 1:21 AM, portefeuille (99.50) wrote:

Radware Carves Niche In Application Delivery

 

currently in the fund (number of shares, ticker, name, current share price (USD), break-even (USD)).

510, RDWR, 38.76, 12.89.
18, FFIV, 130.38, -299.25.
5700, CSCO, 19.47, 22.93.
95, CTXS, 67.68, 45.22.
100, RVBD, 34.13, 4.54.

Report this comment
#94) On December 16, 2010 at 1:38 AM, portefeuille (99.50) wrote:

buy 200 SPY $100 March 2011 put options (SPY110319P00100000), limit 0.65 USD.

Report this comment
#95) On December 16, 2010 at 3:11 AM, portefeuille (99.50) wrote:

buy 155 RBCN, limit 22.70 USD.

currently 445 RBCN shares in the fund with break-even of around 23.57 USD.

Report this comment
#96) On December 16, 2010 at 3:15 AM, portefeuille (99.50) wrote:

sell 130 PANL, limit 28.10 USD.

currently 450 PANL shares in the fund with break-even of around 19.99 USD.

Report this comment
#97) On December 16, 2010 at 3:16 AM, portefeuille (99.50) wrote:

(number of shares, ticker, name, current share price (USD), break-even (USD))

(number of shares, ticker, current share price (USD), break-even (USD))

Report this comment
#98) On December 16, 2010 at 5:12 AM, portefeuille (99.50) wrote:

Bloomberg Businessweek Hot Tech 50

Special Report: Tech Hot Growth Companies 2010

 

currently in the fund.

2 Apple (30 AAPL shares)
5 Aixtron (1485 AIXG)
7 Software AG (200 SOW:GY)
(18 Tech Mahindra (22000 SAYCY:US <-> 44000 SCS:IN) (see this article))
21 Autonomy (430 AU/:LN)
29 Elpida Memory (200 6665:JP)
32 Akamai (165 AKAM)
40 NetApp (1130 NTAP)
42 VMware (21000 EMC and -1000 VMW)
(43 Yahoo Japan (780 YHOO))
47 Cisco (5700 CSCO)

Report this comment
#99) On December 16, 2010 at 7:15 AM, portefeuille3 (97.58) wrote:

sell 2300 IBB, limit 91.60 USD.

Report this comment
#100) On December 16, 2010 at 7:28 AM, portefeuille3 (97.58) wrote:

December 16, 2010, Autonomy May Be Focus of Microsoft, Oracle Bidding, Mail Says

December 15, 2010, MARKET REPORT: Autonomy could score with deal

 

currently 430 AU/:LN shares in the fund with break-even of around 1531.85 p.

Report this comment
#101) On December 16, 2010 at 7:45 AM, portefeuille3 (97.58) wrote:

#100

http://caps.fool.com/Ticker/AUTNF.PK.aspx

http://caps.fool.com/Ticker/AU-.L.aspx

Report this comment
#102) On December 16, 2010 at 7:58 AM, portefeuille (99.50) wrote:

Onyx Pharma CEO Coles: Racing to Market

 

currently 140 ONXX shares in the fund with break-even of around 22.94 USD.

Report this comment
#103) On December 16, 2010 at 10:02 AM, portefeuille (99.50) wrote:

buy 100000 DSCO, limit 0.21 USD.

Report this comment
#104) On December 16, 2010 at 10:18 AM, portefeuille (99.50) wrote:

bought 100000 DSCO 0.205 USD.

Report this comment
#105) On December 16, 2010 at 11:59 AM, portefeuille (99.50) wrote:

buy 16000 ARYX, limit 0.22 USD.

Report this comment
#106) On December 16, 2010 at 12:31 PM, portefeuille (99.50) wrote:

bought 16000 ARYX 0.2115 USD.

sell 12000 ARYX, limit 0.221 USD.

Report this comment
#107) On December 16, 2010 at 12:34 PM, portefeuille (99.50) wrote:

sold 12000 ARYX 0.2211 USD.

Report this comment
#108) On December 16, 2010 at 12:41 PM, portefeuille (99.50) wrote:

sell 200 MNKD, limit 8.68 USD.

Report this comment
#109) On December 16, 2010 at 12:46 PM, portefeuille (99.50) wrote:

sell 1300 ARIA, limit 4.68 USD.

Report this comment
#110) On December 16, 2010 at 12:46 PM, portefeuille (99.50) wrote:

sold 1300 ARIA 4.68 USD.

Report this comment
#111) On December 16, 2010 at 12:49 PM, portefeuille (99.50) wrote:

sell 70000 DSCO, limit 0.226 USD.

Report this comment
#112) On December 16, 2010 at 12:55 PM, portefeuille (99.50) wrote:

sell short (to open) 100 VMW, limit 88.37 USD.

Report this comment
#113) On December 16, 2010 at 2:30 PM, portefeuille (99.50) wrote:

sell 450 SGMO, limit 6 USD.

Report this comment
#114) On December 16, 2010 at 2:59 PM, portefeuille (99.50) wrote:

bought 200 SPY $100 March 2011 put options (SPY110319P00100000) 0.55 USD,
bought 155 RBCN 21.51 USD,
sold 130 PANL 28.10 USD,
sold 2300 IBB, limit 91.95 USD,
sold 450 SGMO 6.00 USD.

Report this comment
#115) On December 17, 2010 at 8:16 AM, portefeuille (99.50) wrote:

sell 70000 DSCO, limit 0.226 USD.

change that to

sell 47000 DSCO, limit 0.223 USD in extended or regular trading.

Report this comment
#116) On December 17, 2010 at 8:26 AM, portefeuille (99.50) wrote:

sell 1800 ITMN, limit 30 USD in extended or regular trading.

Report this comment
#117) On December 17, 2010 at 8:27 AM, portefeuille (99.50) wrote:

sold 1800 ITMN 30.45 USD.

Report this comment
#118) On December 17, 2010 at 8:28 AM, portefeuille (99.50) wrote:

sell 370 ITMN, limit 30.90 USD in extended or regular trading.

Report this comment
#119) On December 17, 2010 at 8:32 AM, portefeuille (99.50) wrote:

InterMune Announces Positive Opinion for Approval of Esbriet (Pirfenidone) in European Union

CHMP summary of positive opinion for Esbriet (pdf)

 

currently 3150 ITMN shares in the fund with break-even of around -4.41 USD.

Report this comment
#120) On December 17, 2010 at 8:46 AM, portefeuille (99.50) wrote:

buy 600 ITMN, limit 30 USD in extended or regular trading.

Report this comment
#121) On December 17, 2010 at 8:47 AM, portefeuille (99.50) wrote:

bought 600 ITMN 28.85 USD.

Report this comment
#122) On December 17, 2010 at 8:56 AM, portefeuille (99.50) wrote:

sell 370 ITMN, limit 30.90 USD in extended or regular trading.

cancel that order.

Report this comment
#123) On December 17, 2010 at 10:05 AM, portefeuille (99.50) wrote:

sell 450 ITMN, limit 29.42 USD.

Report this comment
#124) On December 17, 2010 at 10:10 AM, Momentum21 (93.61) wrote:

good call staying with ITMN...I try not to look back but my goodness it could have made for a nice Friday for me... : )

Report this comment
#125) On December 17, 2010 at 10:27 AM, portefeuille (99.50) wrote:

sold 450 ITMN 29.42 USD.

sell 3400 ARNA, limit 1.66 USD.

Report this comment
#126) On December 17, 2010 at 10:35 AM, portefeuille (99.50) wrote:

sold 3400 ARNA 1.66 USD.

 

#124 Maybe my most important "rule" is to almost never sell all shares (especially of a relatively large position). Following that rule gives me some "peace of mind".

my old ITMN recommendation post.

biopharmaceuticals ITMN

Report this comment
#127) On December 17, 2010 at 10:38 AM, portefeuille (99.50) wrote:

sold short (to open) 100 VMW 88.37 USD.

Report this comment
#128) On December 17, 2010 at 10:40 AM, portefeuille (99.50) wrote:

sell 4000 EMC, limit 22.97 USD.

Report this comment
#129) On December 17, 2010 at 10:41 AM, portefeuille (99.50) wrote:

sold 4000 EMC 22.98 USD.

Report this comment
#130) On December 17, 2010 at 2:12 PM, portefeuille (99.50) wrote:

sell 200 ITMN, limit 34.52 USD.

Report this comment
#131) On December 17, 2010 at 2:13 PM, portefeuille (99.50) wrote:

sold 200 ITMN 34.58 USD.

Report this comment
#132) On December 17, 2010 at 2:19 PM, portefeuille (99.50) wrote:

continued here.

Report this comment

Featured Broker Partners


Advertisement